Liver Regeneration and Tissue Engineering

  • Ji Bao
  • James Fisher
  • Scott L. NybergEmail author
Part of the Stem Cell Biology and Regenerative Medicine book series (STEMCELL)


The liver is one of the largest and most complex organs in the human body. It is a vital organ weighing about 1,500 g and it continuously performs over 500 different functions. As a result, the liver is a vital organ and liver failure in the absence of liver transplantation often results in death to the patient. The shortage of donor livers for transplantation, the demand from industry to develop new drugs and new systems to test their safety, along with the need to better understand the many metabolic pathways of the liver, have been the major driving forces behind liver tissue engineering and advances to create livers synthetically, either in culture or ex vivo or by using animals as in vivo incubators. The liver is also a privileged organ in its ability to regenerate spontaneously in response to acute injury. For these reasons, it has been a major focus of research in tissue engineering and regenerative medicine. However, the ideal source of liver cells (hepatocytes) for synthetic livers has not yet been identified, and numerous research efforts are underway. The ultimate goal of these efforts is to produce an abundant, high quality and readily available source of primary human hepatocytes or synthetic liver tissue constructs for discovery, therapeutic, and diagnostic applications. This chapter explores many recent advances in the field of liver regeneration and liver tissue engineering, and new areas of research and future development.


Hollow Fiber Human Hepatocyte Primary Hepatocyte Hepatocyte Culture Nonparenchymal Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Bioartificial liver


Extracellular matrix


Embryonic stem cell


Induced pluripotent stem cell


Poly (dl-lactide-co-glycolide)


Poly (l-lactic acid)


Spheroid reservoir bioartificial liver


  1. 1.
    Taub R (2004) Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5(10):836–847PubMedCrossRefGoogle Scholar
  2. 2.
    Everhart J, Ruhl C (2009) Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas. Gastroenterology 136:1134–1144PubMedCrossRefGoogle Scholar
  3. 3.
    Gomez-Lechon MJ et al (2003) Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab 4(4):292–312PubMedCrossRefGoogle Scholar
  4. 4.
    Kidambi S et al (2009) Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance. Proc Natl Acad Sci USA 106(37):15714–15719PubMedCrossRefGoogle Scholar
  5. 5.
    McCuskey RS et al (2003) Hepatic microvascular development in relation to the morphogenesis of hepatocellular plates in neonatal rats. Anat Rec A Discov Mol Cell Evol Biol 275(1):1019–1030PubMedCrossRefGoogle Scholar
  6. 6.
    Berry MN, Friend DS (1969) High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43(3):506–520PubMedCrossRefGoogle Scholar
  7. 7.
    Seglen P (1976) Preparation of isolated rat liver cells. Methods Cell Biol 13:29–83PubMedCrossRefGoogle Scholar
  8. 8.
    Yagi T et al (2001) Caspase inhibition reduces apoptotic death of cryopreserved porcine hepatocytes. Hepatology 33(6):1432–1440PubMedCrossRefGoogle Scholar
  9. 9.
    Kunieda T et al (2003) Cryopreservation of primarily isolated porcine hepatocytes with UW solution. Cell Transplant 12(6):607–616PubMedGoogle Scholar
  10. 10.
    Aoki T, Koizumi T, Kobayashi Y, Yasuda D, Izumida Y, Jin Z, Nishino N, Shimizu Y, Kato H, Murai N, Niiya T, Enami Y, Mitamura K, Yamamoto T, Kusano M (2005) A novel method of cryopreservation of rat and human hepatocytes by using encapsulation technique and possible use for cell transplantation. Cell Transplant 14(9):609–620PubMedCrossRefGoogle Scholar
  11. 11.
    Mai G et al (2005) Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Xenotransplantation 12(6):457–464PubMedCrossRefGoogle Scholar
  12. 12.
    Dunn J, Thompkins R, Yarmush M (1992) Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation. J Cell Biol 116:1043–1053PubMedCrossRefGoogle Scholar
  13. 13.
    Yarmush ML, King KR (2009) Living-cell microarrays. Annu Rev Biomed Eng 11:235–257PubMedCrossRefGoogle Scholar
  14. 14.
    Allen JW, Khetani SR, Bhatia SN (2005) In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol Sci 84(1):110–119PubMedCrossRefGoogle Scholar
  15. 15.
    Nyberg S et al (1993) Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng 41:194–203PubMedCrossRefGoogle Scholar
  16. 16.
    Catapano G (1996) Mass transfer limitations to the performance of membrane bioartificial liver support devices. Int J Artif Organs 19(1):18–35PubMedGoogle Scholar
  17. 17.
    David B et al (2004) In vitro assessment of encapsulated C3A hepatocytes functions in a fluidized bed bioreactor. Biotechnol Prog 20(4):1204–1212PubMedCrossRefGoogle Scholar
  18. 18.
    Landry J, Bernier D, Ouellet C, Goyette R, Marceau N (1985) Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J Cell Biol 101:914–923PubMedCrossRefGoogle Scholar
  19. 19.
    Sakai Y et al (1996) Large-scale preparation and function of porcine hepatocyte spheroids. Int J Artif Organs 19:294–301PubMedGoogle Scholar
  20. 20.
    Nyberg S et al (2005) Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver. Liver Transpl 11:901–910PubMedCrossRefGoogle Scholar
  21. 21.
    Brophy CM et al (2009) Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology 49(2):578–586PubMedCrossRefGoogle Scholar
  22. 22.
    Abu-Absi S et al (2002) Structural polarity and functional bile canaliculi in rat hepatocytes spheroids. Exp Cell Res 274:56–67PubMedCrossRefGoogle Scholar
  23. 23.
    Mercer DF et al (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7(8):927–933PubMedCrossRefGoogle Scholar
  24. 24.
    Azuma H et al (2007) Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice. Nat Biotechnol 25(8):903–910PubMedCrossRefGoogle Scholar
  25. 25.
    Bissig KD et al (2010) Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 120(3):924–930PubMedCrossRefGoogle Scholar
  26. 26.
    Gerlach JC et al (2003) Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study. Transplantation 76(5):781–786PubMedCrossRefGoogle Scholar
  27. 27.
    Millis J, Losanoff J (2005) Technology insight: liver support systems. Nat Clin Pract Gastroenterol Hepatol 2:398–405PubMedCrossRefGoogle Scholar
  28. 28.
    Mavri-Damelin D et al (2008) Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia. Biotechnol Bioeng 99(3):644–651PubMedCrossRefGoogle Scholar
  29. 29.
    Demetriou AA et al (2004) Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239(5):660–667, discussion 667–670PubMedCrossRefGoogle Scholar
  30. 30.
    Vassilopoulos G, Wang P-R, Russell D (2003) Transplanted bone marrow regenerates liver by cell fusion. Nature 422:901–904PubMedCrossRefGoogle Scholar
  31. 31.
    Yu J et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917–1920PubMedCrossRefGoogle Scholar
  32. 32.
    Yu J et al (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928):797–801PubMedCrossRefGoogle Scholar
  33. 33.
    Si-Tayeb K et al (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51(1):297–305PubMedCrossRefGoogle Scholar
  34. 34.
    Raya A et al (2010) A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat Protoc 5:647–660PubMedCrossRefGoogle Scholar
  35. 35.
    Khetani SR, Bhatia SN (2008) Microscale culture of human liver cells for drug development. Nat Biotechnol 26(1):120–126PubMedCrossRefGoogle Scholar
  36. 36.
    Gerlach JC et al (1994) Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation 58(9):984–988PubMedCrossRefGoogle Scholar
  37. 37.
    Nedredal GI et al (2009) Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver. Biotechnol Bioeng 104(5):995–1003PubMedCrossRefGoogle Scholar
  38. 38.
    Dhawan A et al (2010) Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 7:288–298PubMedCrossRefGoogle Scholar
  39. 39.
    Ohashi K et al (2007) Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat Med 13:880–885PubMedCrossRefGoogle Scholar
  40. 40.
    Kaihara S et al (2000) Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng 6(2):105–117PubMedCrossRefGoogle Scholar
  41. 41.
    Nahmias Y et al (2006) Endothelium-mediated hepatocyte recruitment in the establishment of liver-like tissue in vitro. Tissue Eng 12(6):1627–1638PubMedCrossRefGoogle Scholar
  42. 42.
    Soto-Gutierrez A et al (2006) Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol 24(11):1412–1419PubMedCrossRefGoogle Scholar
  43. 43.
    Wang S et al ( 2008) Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng 14:227–236Google Scholar
  44. 44.
    Uygun BE et al (2010) Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 16(7):814–820PubMedCrossRefGoogle Scholar
  45. 45.
    Bao J et al (2011) Construction of a portal implantable functional tissue engineered liver using perfusion-decellularized matrix and hepatocytes in rats. Cell Transplant 20:753–766Google Scholar
  46. 46.
    Harland RC, Platt JL (1996) Prospects for xenotransplantation of the liver. J Hepatol 25(2):248–258PubMedCrossRefGoogle Scholar
  47. 47.
    Kanazawa A, Platt J (2000) Prospects for xenotransplantation of the liver. Semin Liver Dis 20:511–522PubMedCrossRefGoogle Scholar
  48. 48.
    Phelps CJ et al (2003) Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299(5605):411–414PubMedCrossRefGoogle Scholar
  49. 49.
    Ekser B et al (2010) Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant 10(2):273–285PubMedCrossRefGoogle Scholar
  50. 50.
    Rahman T, Hodgson H (2000) Animal models of acute hepatic failure. Int J Exp Pathol 81:145–157PubMedCrossRefGoogle Scholar
  51. 51.
    van de Kerkhove MP et al (2004) Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials 25(9):1613–1625PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Mayo ClinicRochesterUSA

Personalised recommendations